(19)
(11) EP 4 489 728 A2

(12)

(88) Date of publication A3:
19.10.2023

(43) Date of publication:
15.01.2025 Bulletin 2025/03

(21) Application number: 23767267.0

(22) Date of filing: 08.03.2023
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
A61K 39/08(2006.01)
 A61K 38/45(2006.01)
A61P 21/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 21/00; A61K 38/4893; C12Y 204/02; A61K 38/45; C12Y 304/24069
 
C-Sets:
  1. A61K 38/4893, A61K 2300/00;
  2. A61K 38/45, A61K 2300/00;
(86) International application number:
PCT/TR2023/050226
(87) International publication number:
WO 2023/172230 (14.09.2023 Gazette 2023/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.03.2022 TR 202203435

(71) Applicant: Bogazici Universitesi
Besiktas/Istanbul (TR)

(72) Inventors:
  • YUCESOY, Can Ali
    Besiktas/ stanbul (TR)
  • KAYA KELES, Cemre Su
    70193 Stuttgart (DE)

(74) Representative: Sögüt, Onur Ömer 
Terra Patent Limited Sirketi Hasanpasa Mahallesi Nabizade Sokak, No: 82/A Kadiköy
34722 Istanbul
34722 Istanbul (TR)

   


(54) A DRUG FOR USE IN THE TREATMENT OF MUSCLE SPASTICITY BY CHEMICAL MUSCLE DENERVATION